Cargando…

Efficacy of radioactive iodine treatment of graves’ hyperthyroidism using a single calculated (131)I dose

OBJECTIVE: To evaluate the success rate of therapeutic administration of a single calculated (131)I activity for eliminating hyperthyroidism due to Graves’ disease. METHODS AND MATERIALS: Patients with Graves’ hyperthyroidism underwent pinhole thyroid imaging, 24-h radioactive iodine uptake (RAIU) m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wong, Ka Kit, Shulkin, Barry L., Gross, Milton D., Avram, Anca M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6260735/ https://www.ncbi.nlm.nih.gov/pubmed/30505461 http://dx.doi.org/10.1186/s40842-018-0071-6

Ejemplares similares

Outcomes of Radioactive Iodine ((131)I) Therapy among Hyperthyroid patients
por: Khan, Muhammad Sajjad Ali, et al.
Publicado: (2023)

Transient cytotoxicity of (131)I beta radiation in hyperthyroid patients treated with radioactive iodine
por: Sundaram, P. Shanmuga, et al.
Publicado: (2011)

Predictive factors for the outcomes of Graves’ disease patients with radioactive iodine ((131)I) treatment
por: Xing, Yu-Zhuo, et al.
Publicado: (2020)

Risk factors of hepatic dysfunction in patients with Graves’ hyperthyroidism and the efficacy of (131)iodine treatment
por: Wang, Renfei, et al.
Publicado: (2017)

Treating Hyperthyroidism with Radioactive Iodine
por: Harding, L K
Publicado: (1993)

Estimation of effective half life of clearance of radioactive Iodine ((131)I) in patients treated for hyperthyroidism and carcinoma thyroid
por: Ravichandran, R, et al.
Publicado: (2010)

The assessment of radio-adaptive response in graves' hyperthyroidism patients following radioactive iodine uptake
por: Fazeli, Zahra, et al.
Publicado: (2018)

Impact of lithium on radioactive iodine therapy for hyperthyroidism
por: Lingudu, Brahmanandam, et al.
Publicado: (2014)

Incidence of Hypothyreoidism after Radioactive Iodine–I131 Treatment in Dependance of Hyperthyreoidism Etiology and Therapy Dose
por: Beslic, Nermina, et al.
Publicado: (2017)

A mathematical model of optimized radioiodine-131 therapy of Graves' hyperthyroidism
por: Doi, Suhail AR, et al.
Publicado: (2001)

Radioactive Iodine-131 as a Definitive Treatment in Rare Association of Down Syndrome With Hyperthyroidism: A Case Report and Review of Literature
por: Khan, Shoukat H., et al.
Publicado: (2017)

SUN-510 Prolonged RAIA Induced Thyroiditis After 131 I Therapy for Graves’ Hyperthyroidism
por: Aljaberi, Asma Khaled, et al.
Publicado: (2020)

MON-590 Outcomes Following Radioactive Iodine Therapy (RAI) in Hyperthyroid Patients with Grave’s Disease and Toxic Nodular Disease
por: Aljenaee, Khaled, et al.
Publicado: (2019)

Long term follow up of patients treated for hyperthyroidism with low dose radioactive iodine.
por: Blair, A. L., et al.
Publicado: (1980)

Association of Radioactive Iodine Treatment With Cancer Mortality in Patients With Hyperthyroidism
por: Kitahara, Cari M., et al.
Publicado: (2019)

(131)I thyroid activity and committed dose assessment among family members of patients treated with radioactive iodine
por: Brudecki, K., et al.
Publicado: (2020)

Cure Rates After a Single Dose of Radioactive Iodine to Treat Hyperthyroidism: The Fixed-Dose Regimen
por: Madu, Nneka M, et al.
Publicado: (2022)

Therapeutic applications of radioactive (131)iodine: Procedures and incidents with capsules
por: Al Aamri, Marwa, et al.
Publicado: (2016)

Received dose variability after administration of I‐131 for treatment of hyperthyroidism in cats
por: Busser, Suzanne, et al.
Publicado: (2021)

Change in BMI after radioactive iodine ablation for graves disease
por: Chen, Melinda, et al.
Publicado: (2017)

Clinical Outcomes of Repeated Radioactive Iodine Therapy for Graves’ Disease
por: Kim, Min Joo, et al.
Publicado: (2022)

Iodine-131 induced hepatotoxicity in previously healthy patients with Grave’s disease
por: Jhummon, Navina Priya, et al.
Publicado: (2013)

DIFFERENTIATED THYROID CANCER IN PEDIATRIC POPULATION (≤18 YEARS): POSTOPERATIVE TREATMENT WITH RADIOACTIVE IODINE (I-131)
por: Prpić, Marin, et al.
Publicado: (2019)

No impact of dietary iodine restriction in short term development of hypothyroidism following fixed dose radioactive iodine therapy for Graves’ disease
por: Jacob, Jubbin Jagan, et al.
Publicado: (2015)

Probiotic Bacteria Cannot Mitigate the Adverse Effects of Radioactive Iodine-131 Treatment
por: Mortazavi, Seyed Mohammad Javad, et al.
Publicado: (2023)

Dependence of radioactive iodine-131 capture by the lacrimal ducts on the tear production level
por: Yartsev, Vasily D, et al.
Publicado: (2023)

Factors Predicting Treatment Failure in Patients Treated with Iodine-131 for Graves’ Disease
por: Manohar, Kuruva, et al.
Publicado: (2013)

Clinical experience with radioactive iodine in the treatment of childhood and adolescent Graves' disease
por: Cury, Adriano N, et al.
Publicado: (2012)

Anaplastic Thyroid Carcinoma Following Radioactive Iodine Therapy for Graves' Disease
por: Kim, Sun Hwa, et al.
Publicado: (2013)

Chylothorax Associated with Substernal Goiter in Graves’ Disease Treated with Radioactive Iodine
por: Young Oh, Seo, et al.
Publicado: (2017)

Graves' Disease-Related Pancytopenia Improved after Radioactive Iodine Ablation
por: Hamid, Omnia A., et al.
Publicado: (2020)

Effect of liver dysfunction on outcome of radioactive iodine therapy for Graves’ disease
por: Ze, Yuyang, et al.
Publicado: (2022)

Association between radioactive iodine uptake and neutropenia in untreated Graves’ disease
por: Yang, Qian, et al.
Publicado: (2023)

Effectiveness of Fixed Dose Radioactive Iodine (RAI) for the Treatment of Hyperthyroidism: Experience of a Teaching Hospital in South West Nigeria
por: Enyi Ejeh M, John, et al.
Publicado: (2013)

Alternating hyperthyroidism and hypothyroidism in Graves’ disease
por: Wong, Mimi, et al.
Publicado: (2018)

Outcome of (131)I therapy in hyperthyroidism using a 550MBq fixed dose regimen
por: Lewis, Anthony, et al.
Publicado: (2013)

Radioactive (131)Iodine Body Burden and Blood Dose Estimates in Treatment for Differentiated Thyroid Cancer by External Probe Counting
por: Ravichandran, Ramamoorthy, et al.
Publicado: (2016)

Thyroid Isthmus Length and Iodine Turnover as Predictors of Successful Radioactive Iodine Therapy in Patients with Graves' Disease
por: Park, Se Hee, et al.
Publicado: (2017)

LBODP096 High Failure Rate Of Radioactive Iodine-131 (Rai) Therapy For The Treatment Of Grave's Disease And Toxic Multinodular Goiter In An Urban Municipal Hospital Clinic
por: Handoo, Maryam Manzoor, et al.
Publicado: (2022)

Radioactive Body Burden Measurements in (131)Iodine Therapy for Differentiated Thyroid Cancer: Effect of Recombinant Thyroid Stimulating Hormone in Whole Body (131)Iodine Clearance
por: Ravichandran, Ramamoorthy, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_sqahe19tq6cm9qh9099b5vht74